Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b

O S Levine1, R Lagos, A Muñoz

  • 1Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Insights

The Haemophilus influenzae type b (Hib) vaccine significantly reduces pneumonia hospitalizations in young children. This Hib conjugate vaccine prevented 26% of pneumonia cases with likely bacterial infection indicators.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Pneumonia is a major cause of hospitalization in infants and young children.
  • Haemophilus influenzae type b (Hib) is a significant bacterial pathogen.
  • The impact of Hib vaccination on pneumonia burden requires further elucidation.

Purpose of the Study:

  • To assess the burden of pneumonia preventable by Haemophilus influenzae type b (Hib) vaccination.
  • To evaluate the efficacy of the PRP-T Hib conjugate vaccine in preventing pneumonia hospitalizations.

Main Methods:

  • A randomized controlled trial was conducted in Santiago, Chile.
  • Infants received either the PRP-T Hib conjugate vaccine combined with DTP or DTP vaccine alone.
  • Pneumonia was defined by hospitalization with indicators of likely bacterial infection.

Main Results:

  • The PRP-T vaccine reduced pneumonia incidence by 22% in children aged 4-23 months.
  • Specifically, it reduced pneumonia with alveolar consolidation or pleural effusion by 22%.
  • Overall protection against pneumonia with likely bacterial infection indicators was 26%, preventing 2.5 cases per 1000 children annually.

Conclusions:

  • Hib vaccination offers substantial protection against nonbacteremic pneumonia, especially cases with signs of bacterial infection.
  • Hib vaccination prevented significantly more nonbacteremic pneumonia cases than meningitis cases in infants.
  • The full impact of Hib vaccination on pneumonia may be underestimated by traditional culture methods.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...